IVOS Medical Logo teal

IVOS Medical Receives Phase II SBIR Award from the National Institutes of Health for $1.9M

Jan 22, 2025 | Press Release

Irvine, CA – January, 22, 2025, – IVOS Medical, Inc., a startup medical device company specializing in airway management, today announced it has been awarded approximately $1.9M through a Small Business Innovation Research (SBIR) Phase II grant supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health. This Phase II funding follows an NIH SBIR Phase I grant ($247,334) awarded in Fiscal Year 2022 to test the feasibility of the company’s innovative technology.

IVOS Medical is developing an economical, disposable video laryngoscope sheath that incorporates novel features to help maintain clear vision during intubation and increase first-pass success in emergency, soiled intubations. 

“I am grateful for the tremendous support from the NHLBI, particularly Dr. Siddharth Shenoy, Program Officer in the Division of Lung Diseases, for backing our research and advancing this lifesaving technology,” said Gabriel Punsalan, CRNA, MS, CEO and Co-Founder of IVOS Medical. “Additionally, we appreciate the support of the University of California Irvine Medical Center’s Departments of Anesthesiology and Emergency Medicine clinicians in testing the BOSS G4 during feasibility studies. Finally, we thank University of California Irvine Beall Applied Innovation for accepting us into their accelerator program, providing access to invaluable advisors, workspace, and investors to bring this technology closer to production.” 

“This SBIR Phase II award underscores the importance of IVOS’s value proposition, our product, and the team’s ability to successfully execute Phase I milestones,” added Francis Duhay, MD, MBA, IVOS Vice President of Business Development. “Our current aims focus on completing product development and achieving clinical validation, bringing us one giant step closer to the patients who would benefit the most.”

DISCLAIMER: Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R44HL164325. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About IVOS Medical
IVOS Medical is a medical device company committed to advancing airway management technology, particularly for challenging intubations. Its flagship product, the patent-pending Breathing Optimization and Suction System (BOSS™) G4™, enhances critical intubation success through video laryngoscopy. Founded by clinicians with extensive experience in airway management, the company addresses the significant challenges health care providers face during critical and emergency intubations. Supported by over $2 million in non-dilutive NIH SBIR funding and exclusively licensed from UC Irvine, IVOS Medical remains focused on elevating patient safety and healthcare efficiency through better intubation tools. For more information, visit www.ivosmedical.com or email: info@ivosmedical.com.

###

The IVOS BOSS G4 is a trademark of IVOS MEDICAL, Inc. All other product or service names are the property of their respective owners.

Obstructed Vision in Soiled Airways

0-11 sec:

The initial insertion of the video laryngoscope resulted in obstruction of the camera view due to fluids in the oral cavity. The device was removed from the mouth, and the lens was manually cleaned to restore the camera to baseline functionality before being reinserted.

12-21 sec:

Once the video laryngoscope was reinserted into the oral cavity, critical time had already been lost, as the simulated patient remained apneic and gastric fluids continued to enter the lungs.

22-30 sec:

A Cormack-Lehane grade 1 view was achieved after aggressive suctioning with a Yankauer suction catheter. This provided clear visualization for the healthcare provider to insert the endotracheal tube using indirect visualization.

Obstructed Vision in Soiled Airways

0-13 sec:

The video laryngoscope is equipped with the IVOS BOSS G4™ system. The device integrates gas flow into the handle to continuously provide a clear camera window throughout the entire intubation process, without requiring removal of the device from the patient’s mouth.

14-27 sec:

The G4’s integrated suction channel removes oral cavity fluids and reduces the potential for aspirate to enter the lungs. Maintaining a clear view of the airway in an emergency setting can increase first-pass success, thereby reducing morbidity and mortality in patients.

28-37 sec:

The patient remains apneic for only a minimal amount of time while the healthcare provider inserts the endotracheal tube into the trachea and secures the airway for lifesaving ventilation.